| Title | The prevention of type 2 diabetes. | | Author(s) | Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM, , for the Diabetes Prevention Program Research Group | | Institution | JP Crandall is Associate Professor of Clinical Medicine at Albert Einstein College of Medicine, Bronx, NY. | | Source | Nat Clin Pract Endocrinol Metab 2008 May 20. | | Abstract | Type 2 diabetes mellitus (T2DM) affects more than 7% of adults in the US and leads to substantial personal and economic burden. In prediabetic states insulin secretion and action-potential targets of preventive interventions-are impaired. In trials lifestyle modification (i.e. weight loss and exercise) has proven effective in preventing incident T2DM in high-risk groups, although weight loss has the greatest effect. Various medications (e.g. metformin, thiazolidinediones and acarbose) can also prevent or delay T2DM. Whether diabetes-prevention strategies also ultimately prevent the development of diabetic vascular complications is unknown, but cardiovascular risk factors are favorably affected. Preventive strategies that can be implemented in routine clinical settings have been developed and evaluated. Widespread application has, however, been limited by local financial considerations, even though cost-effectiveness might be achieved at the population level. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 18493227 |
|
